This scoring will determine the targets of therapy for reduction of apolipoprotein B-containing lipoproteins.
其危险得分将决定应用何种治疗方法以降低包括血清载脂蛋白B在内的脂蛋白。
Should the apolipoprotein B/A1 ratio become the routine lipid measurement for cardiovascular risk stratification?
是否载脂蛋白B/A1比值能作为常规脂质测量用来进行心血管危险分层？
Should the apolipoprotein B/A1 ratio become the routine lipid measurement for cardiovascular risk stratification?
是否载脂蛋白B/A1比值能作为常规脂质测量用来进行心血管危险分层？
应用推荐